Use of artemether-lumefantrine in the treatment of asymptomatic-malaria infection in HIV-positive and HIV-negative Nigerian adults

@inproceedings{ChijiokeNwauche2014UseOA,
  title={Use of artemether-lumefantrine in the treatment of asymptomatic-malaria infection in HIV-positive and HIV-negative Nigerian adults},
  author={Ifevinwa Chijioke-Nwauche},
  year={2014}
}
Malaria /HIV co-infection is a major challenge to public health in developing countries and yet potential drug-drug interactions between antimalarial and antiviral regimens have not been adequately investigated in people with both HIV and Plasmodium falciparum infections. Earlier studies on the use of artemether-lumefantrine (AL) in Nigeria have neither addressed its use in HIV-positive subjects nor in asymptomatic-malaria infection. The present study investigated associations between drug… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 24 REFERENCES

Understanding the pharmacokinetics of Coartem®

VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults

Pauline Byakika-Kibwika, Mohammed Lamorde, +14 authors Concepta Merry
  • The Journal of antimicrobial chemotherapy
  • 2012
VIEW 1 EXCERPT